HSBC Global Research raised the target price for Innovent Bio (01801) to HKD58 from HKD55 and maintained the "buy" rating.
The research house said it raises 2024-26e revenue estimates by 2-6% and expects 2024-26e revenue of RMB7.9bn, RMB10.0bn and RMB13.2bn, respectively.
16/09/2024 15:55
{I-bank focus}HSBC raises Innovent Bio (01801) to HKD58
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
